Login
$CAVA
$51.85 +$0.32 (0.61%) Live

Unaudited condensed consolidated balance sheets

In millions of USD, except per-share amounts
Q2 FY2026
As of Jul 12, 2026
Q1 FY2026
As of Apr 19, 2026
Q4 FY2025
As of Dec 28, 2025
Q3 FY2025
As of Oct 5, 2025
Q2 FY2025
As of Jul 13, 2025
Q1 FY2025
As of Apr 20, 2025
Q4 FY2024
As of Dec 29, 2024
Q3 FY2024
As of Oct 6, 2024
Q2 FY2024
As of Jul 14, 2024
Q1 FY2024
As of Apr 21, 2024
Q4 FY2023
As of Dec 31, 2023
Q3 FY2023
As of Oct 1, 2023
Q2 FY2023
As of Jul 9, 2023
ASSETS
Current assets:
Cash and cash equivalents
Trade accounts receivable, net
Other accounts receivable
Investments at fair value (amortized cost of $113,107 and $109,951, respectively)
Inventories
Prepaid expenses and other
Total current assets
Property and equipment, net
Operating lease assets
Goodwill
Intangible assets, net
Deferred income taxes
Other long-term assets
Total assets
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable
Accrued expenses and other
Operating lease liabilities, current
Total current liabilities
Deferred income taxes
Operating lease liabilities
Other long-term liabilities
Total liabilities
Redeemable preferred stock, par value $0.0001 per share; 250,000 and 111,874 shares authorized; zero and 95,204 shares issued and outstanding, respectively
Stockholders’ equity:
Common stock, par value $0.0001 per share; 2,500,000 shares authorized; 116,804 and 116,127 issued and outstanding, respectively
Treasury stock, at cost; 1,431 shares
Additional paid-in capital
Accumulated deficit
Accumulated other comprehensive (loss) income
Total stockholders’ equity
Total liabilities and stockholders’ equity

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support